Ignite Creation Date:
2025-12-25 @ 2:39 AM
Ignite Modification Date:
2025-12-30 @ 4:44 PM
Study NCT ID:
NCT05085834
Status:
COMPLETED
Last Update Posted:
2025-06-12
First Post:
2019-07-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Zinc Effect on Inflammation and Cardiovascular Risk in HIV
Sponsor:
University Hospitals Cleveland Medical Center
Organization:
Study Overview
Official Title:
Zinc Effect on Inflammation and Cardiovascular Risk in HIV
Status:
COMPLETED
Status Verified Date:
2025-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To study the effect of short-term zinc supplementation on improving inflammation, metabolic, and cardiovascular risk among HIV infected patients on stable anti-retroviral therapy
Detailed Description:
This study will focus on subjects with documented zinc deficiency (levels \<75 µg/dl) as group most likely to benefit from the zinc supplementation. The investigators also acknowledge that zinc may be beneficial in all HIV subjects, regardless of the plasma zinc level; however initial studies should be done in subjects with low zinc levels as they are more likely to benefit.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 1R21AT009153 | NIH | None | https://reporter.nih.gov/quic… | View |